| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/17/2003 | US20030073137 Periostin-based diagnostic assays |
| 04/17/2003 | US20030073132 Detecting modulators of brain membrane protein; obtain membrane protein, incubate with ligand and labeled compound, measure level of binding |
| 04/17/2003 | US20030073123 Detection of modulators of gene transcription inhibition; obtain sample of cells, incubate with modulator, monitor transcription pattern, compare to control, evaluate for transcription inhibition |
| 04/17/2003 | US20030073119 Screening for melanoma in skin sample; obtain skin extract nucleotide sequences, incubate with cyclin sequence probe, determine concentration of bound probe, compare to control, evaluate for skin melanoma |
| 04/17/2003 | US20030073118 MID 9002, a human sulfatase family member and uses therefor |
| 04/17/2003 | US20030073117 Novel protein and gene encoding the protein |
| 04/17/2003 | US20030073114 Isolating preferential nucleotide sequences from library; obtain sample from library, incubate with probe, screen, detect signal from probe, recover library clone, evaluate for presence of preferential nucleotide sequences |
| 04/17/2003 | US20030073111 Biologically active alternative form of the IKKalpha IkappaB kinase |
| 04/17/2003 | US20030073109 Isolation of microorganism expressing preferential gene; obtain nucleotide sequences, mutate, insert into vector, transform bacteria, express polypeptide in vector, recover bacteria expressing polypeptide |
| 04/17/2003 | US20030073108 Probe composition containing a binding domain and polymer chain and methods of use |
| 04/17/2003 | US20030073107 Diagnostic assay for cancer susceptibility |
| 04/17/2003 | US20030073104 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus |
| 04/17/2003 | US20030073096 Pin1 as a marker for prostate cancer |
| 04/17/2003 | US20030073095 Nucleotide sequences coding bacterial protein for use in the treatment and prevention of bacterial infections |
| 04/17/2003 | US20030073094 Stress proteins and uses therefor |
| 04/17/2003 | US20030073092 Modeling framework for predicting the number, type, and distribution of crossovers in directed evolution experiments |
| 04/17/2003 | US20030073086 Detecting preferential target in sample; provide microarray, incubate with sample, allow binding, detect signal from bound particles |
| 04/17/2003 | US20030073080 Genetically engineered viral nucleotide sequences for use as tool in gene therapy and vaccine development |
| 04/17/2003 | US20030073076 Analyzing modulators or treatments of fibroproliferative diseases; obtain sample, incubate with modulator, monitor marker expression, decreased expression indicate effective modulator |
| 04/17/2003 | US20030073075 Oligonucleotides labeled with stable isotopes and a method for detecting the same |
| 04/17/2003 | US20030073072 Chimeric adenoviruses |
| 04/17/2003 | US20030073042 Process and materials for formation of patterned films of functional materials |
| 04/17/2003 | US20030072951 Substrate for immobilizing physiological material, and method of fabricating same |
| 04/17/2003 | US20030072938 Trans-lentiviral vector particles and transduction of eukaryotic cells therewith |
| 04/17/2003 | US20030072844 Phosphatases with improved phytase activity |
| 04/17/2003 | US20030072796 For activating T lymphocytes in vitro for the treatment of disease conditions |
| 04/17/2003 | US20030072773 Vaccines |
| 04/17/2003 | US20030072772 Sub-unit vaccine for infectious pancreatic necrosis virus |
| 04/17/2003 | US20030072771 Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142 |
| 04/17/2003 | US20030072769 Used in the manufacture of vaccines, therapy, prophylaxis, drug screening |
| 04/17/2003 | US20030072767 Compositions and methods for WT1 specific immunotherapy |
| 04/17/2003 | US20030072765 For therapy and prophylaxis of bacterial infections |
| 04/17/2003 | US20030072764 Mucosal boosting following parenteral priming |
| 04/17/2003 | US20030072762 For enhancing Fc receptor-mediated antigen presentation, vaccines |
| 04/17/2003 | US20030072759 Administering to a patient afflicted with a gastrointestinal tumor, a murine monoclonal antibody which specifically binds to an epitope of 17-1A antigen, the antibody being administered parenterally in multiple doses |
| 04/17/2003 | US20030072757 For use in research, diagnostic, and therapeutic agent screening applications |
| 04/17/2003 | US20030072752 Two novel genes from psoriatic epidermis: psoriastatin type i and psoriastatin type ii |
| 04/17/2003 | US20030072742 Enhancement of immune response using targeting molecules |
| 04/17/2003 | US20030072736 Human tumor necrosis factor receptor TR16 |
| 04/17/2003 | US20030071835 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030071834 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | DE10139783C1 Zellzusammensetzungen zur Behandlung von Osteoarthrose, sowie Verfahren zu deren Herstellung Cell compositions for the treatment of osteoarthritis, as well as processes for their preparation |
| 04/17/2003 | CA2748974A1 Manipulation of flavonoid biosynthesis in plants |
| 04/17/2003 | CA2718802A1 Recombinant nucleic acids comprising regions of ad6 |
| 04/17/2003 | CA2464662A1 Modulation of the expression of genes dependent on stat-1 |
| 04/17/2003 | CA2463556A1 Methods for growing and imprinting fish using an odorant |
| 04/17/2003 | CA2463553A1 Gastrointestinal chemosensory receptors |
| 04/17/2003 | CA2463453A1 Methods of preparing a targeting vector and uses thereof |
| 04/17/2003 | CA2463339A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | CA2463093A1 Separation medium, its preparation and its use |
| 04/17/2003 | CA2462920A1 Method and device for isolating rna samples |
| 04/17/2003 | CA2462900A1 Reagents and methods useful for detecting diseases of the breast |
| 04/17/2003 | CA2462873A1 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 04/17/2003 | CA2462868A1 Arrays having clustered arrangements and methods of making and using them |
| 04/17/2003 | CA2462842A1 Method of selecting barley variety, barley .beta.-amylase gene and process for producing malt alcoholic beverage |
| 04/17/2003 | CA2462736A1 Randomly ordered arrays and methods of making and using |
| 04/17/2003 | CA2462687A1 Novel class ii cytokine receptor |
| 04/17/2003 | CA2462531A1 Phagemid display system |
| 04/17/2003 | CA2462291A1 Methods and compositions for treating dermal lesions |
| 04/17/2003 | CA2462185A1 Methods for modulating activity of the fxr nuclear receptor |
| 04/17/2003 | CA2461824A1 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
| 04/17/2003 | CA2461655A1 Nogo receptor-mediated blockade of axonal growth |
| 04/17/2003 | CA2461435A1 Angiopoietin-2 specific binding agents |
| 04/17/2003 | CA2461429A1 Peptides and related compounds having thrombopoietic activity |
| 04/17/2003 | CA2461343A1 Mammalian c-type lectins |
| 04/17/2003 | CA2461315A1 Toll-like receptor 3 signaling agonists and antagonists |
| 04/17/2003 | CA2461266A1 Novel formate dehydrogenase tolerant to halogen compounds and process for producing the same |
| 04/17/2003 | CA2461064A1 Inhibition of stat-1 |
| 04/17/2003 | CA2461058A1 Manipulation of flavonoid biosynthesis in plants |
| 04/17/2003 | CA2460686A1 An efficient system for rna silencing |
| 04/17/2003 | CA2460625A1 Structural and cytoskeleton-associated proteins |
| 04/17/2003 | CA2460480A1 Molecules for disease detection and treatment |
| 04/17/2003 | CA2460476A1 Protein modification and maintenance molecules |
| 04/17/2003 | CA2458645A1 Intracellular signaling molecules |
| 04/17/2003 | CA2458464A1 Monoclonal and cdr-grafted antibodies specific for human kdr |
| 04/17/2003 | CA2429327A1 Method for analyzing mass spectra |
| 04/17/2003 | CA2426384A1 Antibody inhibiting vplf activity |
| 04/16/2003 | EP1302901A1 Method, system and program of indicating expression phenomenon of biosystem |
| 04/16/2003 | EP1302549A2 Process for discriminating sequence variants |
| 04/16/2003 | EP1302546A2 Method of evaluating drug efficacy and toxicity |
| 04/16/2003 | EP1302543A1 Splicing as target to identify pharmaceutical preparations |
| 04/16/2003 | EP1302542A1 Novel physiologically active peptide and use thereof |
| 04/16/2003 | EP1302541A1 Receptor protein specifically recognizing bacterial dna |
| 04/16/2003 | EP1302540A2 Generation of diversity in combinatorial libraries |
| 04/16/2003 | EP1302538A2 Three dimensional crystal structure of human sorbitol dehydrogenase and uses thereof |
| 04/16/2003 | EP1302537A1 Novel glucose-6-phosphate dehydrogenase |
| 04/16/2003 | EP1302472A1 Molecules capable of binding to telomere and the like and method with the use of the same |
| 04/16/2003 | EP1302104A1 P300 transgenic animal |
| 04/16/2003 | EP1301796A2 A method for extracting quantitative information relating to interactions between cellular components |
| 04/16/2003 | EP1301795A2 Method of identifying and/or isolating stem cells |
| 04/16/2003 | EP1301794A2 Method for quantification of akt protein expression |
| 04/16/2003 | EP1301637A2 Dna vaccines encoding hiv accessory proteins |
| 04/16/2003 | EP1301634A2 A METHOD AND AN ALGORITHM FOR mRNA EXPRESSION ANALYSIS |
| 04/16/2003 | EP1301632A2 Nested sorting and high throughput screening |
| 04/16/2003 | EP1301631A1 Novel dna polymerase iii holoenzyme delta subunit nucleic acid molecules and proteins |
| 04/16/2003 | EP1301630A2 Diagnostic method for the identification of foetal dna in a maternal sample |
| 04/16/2003 | EP1301629A2 Improved capture and detection format versatility for dipstick assays |
| 04/16/2003 | EP1301628A2 Improved capture and detection of target nucleic acid in dipstick assays |
| 04/16/2003 | EP1301627A2 Improved detection signal and capture in dipstick assays |
| 04/16/2003 | EP1301625A2 Nanoparticles having oligonucleotides attached thereto and uses therefor |